Spots Global Cancer Trial Database for ercc1
Every month we try and update this database with for ercc1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Biomarker Directed Treatment in Metastatic Colorectal Cancer | NCT01703390 | Metastatic Colo... | FOLFIRI + Cetux... modifiedFOLFOX6... | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer | NCT00705549 | Non-Small-Cell ... | Gemcitabine Cisplatin Docetaxel Cisplatin Vinorelbine Pemetrexate | 18 Years - | Hellenic Oncology Research Group | |
| Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1 | NCT01524575 | Metastatic Panc... ERCC1 | gemcitabine and... | 18 Years - | University of Hawaii | |
| Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer | NCT00705549 | Non-Small-Cell ... | Gemcitabine Cisplatin Docetaxel Cisplatin Vinorelbine Pemetrexate | 18 Years - | Hellenic Oncology Research Group | |
| A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer | NCT01967875 | Stomach Neoplas... | Capecitabine+Ci... Docetaxel+Capec... | 18 Years - 65 Years | China Medical University, China | |
| Gemcitabine and Oxaliplatin in the Management of Metastatic Pancreatic Cancers With Low Expression of ERCC1 | NCT01524575 | Metastatic Panc... ERCC1 | gemcitabine and... | 18 Years - | University of Hawaii | |
| Biomarker Directed Treatment in Metastatic Colorectal Cancer | NCT01703390 | Metastatic Colo... | FOLFIRI + Cetux... modifiedFOLFOX6... | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer | NCT01967875 | Stomach Neoplas... | Capecitabine+Ci... Docetaxel+Capec... | 18 Years - 65 Years | China Medical University, China | |
| Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC | NCT00499109 | Non-Small Cell ... | Docetaxel Vinorelbine Carboplatin Gemcitabine | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design | NCT02128906 | Squamous Cell C... | Cisplatin IMRT Docetaxel Cetuximab | 18 Years - | University of Pittsburgh | |
| A Phase 2 Trial of Optimizing Platinum-Based Chemotherapy Based on ERCC1 Expression as First-Line Treatment in Patients With Locally Advanced or Metastatic Gastric Cancer | NCT01967875 | Stomach Neoplas... | Capecitabine+Ci... Docetaxel+Capec... | 18 Years - 65 Years | China Medical University, China | |
| Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design | NCT02128906 | Squamous Cell C... | Cisplatin IMRT Docetaxel Cetuximab | 18 Years - | University of Pittsburgh |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
